Replies to post #17557 on General Stock Ideas

[ombowstring]

Actually, several of those doctors have been so impressed with leronlimab that they have signed on to take part in the M2M Phase 2 trial -

https://clinicaltrials.gov/ct2/show/NCT04343651?term=Leronlimab&draw=2&rank=2

They are seeing the results of the trial because they are observing that some participants are rapidly recovering while others aren't. Additionally, Patterson is analyzing the clinical data as it comes in. It doesn't take a Nobel Laureate to figure out...

So, with that knowledge, you can load up the truck and the boat on Monday morning notwithstanding another short attack, but who can pick a bottom? But you must be willing to hold until the impending catalysts play out. You can be thankful for the short attacks that have driven the price down this low.

"Anecdotes don't come off life support!" - Bruce Patterson